Variant Linked to Attention-Deficit Hyperactivity

Article

In children with attention-deficit/hyperactivity disorder, those with the catechol-O-methyltransferase (COMT) Val108/158Met polymorphism are more likely to demonstrate poor task-oriented behavior, according to a report published online June 25 in Neuropsychopharmacology.

THURSDAY, June 26 (HealthDay News) -- In children with attention-deficit/hyperactivity disorder, those with the catechol-O-methyltransferase (COMT) Val108/158Met polymorphism are more likely to demonstrate poor task-oriented behavior, according to a report published online June 25 in Neuropsychopharmacology.

Sarojini Sengupta, M.D., of McGill University in Montreal, Canada, and colleagues conducted a double-blind, placebo-controlled crossover study of 188 patients aged 6 to 12 (159 boys and 29 girls) to assess the association between the polymorphism and task-oriented behavior, as well as the response of this behavior with methylphenidate treatment.

The researchers found that the COMT Val108/158Met polymorphism significantly modulated task-oriented behavior, and that children in the Met-Met and Val-Met genotype groups had significantly lower total Restricted Academic Situation Scale scores, which measure behavior in a simulated classroom, than children with the Val-Val genotype. They also found that the COMT Val108/158Met polymorphism was specifically associated with 'off-task' behavior.

"However, no genotype by treatment interaction was observed. These results suggest that the COMT Val108/158Met polymorphism modulates task-oriented behavior, but it does not modulate the response of this behavior with methylphenidate treatment," the authors write. "If these profiles are confirmed in a larger group of patients, this may help in understanding the pathogenesis of this very common childhood disorder."

One of the researchers received consultancy honoraria from Janssen-Ortho and Pfizer Canada.

AbstractFull Text

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.